GKV Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.79M	Buy	4,028 +100	+3%	+$44.5K	0.79%	34
2025 Q1	$1.9M	Buy	3,928 +190	+5%	+$92.1K	0.95%	31
2024 Q4	$1.51M	Buy	+3,738	New	+$1.51M	0.61%	43